LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Strona główna・Stock List・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Open

SectorHealthcare

547.4 -1.21

Buy Sell

Overview

Share price change

24h

Current

Min

543.63

Max

554.7

Key metrics
By Trading Economics
Income	-72M -114M
Sales	74M 287M
EPS	-4.956
Profit margin	-39.75
Employees	528
EBITDA	-75M -114M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+5.32% upside

Market Stats
By TradingEconomics
Market Cap	3.5B 13B
Previous open	548.61
Previous close	547.4

News Sentiment

By Acuity

50%

159 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

263.2 / 277.1 Support & Resistance

Madrigal Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 gru 2025, 23:50 UTC

Hot Stocks

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 gru 2025, 23:20 UTC

Earnings

Correction to Micron Logs Sales Jump Article

17 gru 2025, 23:07 UTC

Earnings

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 gru 2025, 21:37 UTC

Earnings

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 gru 2025, 23:53 UTC

Market Talk

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 gru 2025, 23:43 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 gru 2025, 23:06 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 gru 2025, 23:05 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 gru 2025, 23:04 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 gru 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 gru 2025, 23:02 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 gru 2025, 22:59 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 gru 2025, 22:57 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 gru 2025, 22:56 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 gru 2025, 22:55 UTC

Acquisitions, Mergers, Takeovers

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 gru 2025, 22:49 UTC

Market Talk

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 gru 2025, 21:58 UTC

Earnings

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 gru 2025, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

17 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 gru 2025, 21:46 UTC

Earnings

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 gru 2025, 21:20 UTC

Earnings

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 gru 2025, 21:10 UTC

Earnings

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 gru 2025, 21:05 UTC

Earnings

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 gru 2025, 21:04 UTC

Earnings

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 gru 2025, 21:04 UTC

Earnings

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 gru 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 gru 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 gru 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 gru 2025, 21:02 UTC

Earnings

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 gru 2025, 21:01 UTC

Earnings

Micron Technology 1Q Rev $13.64B >MU

Peer Comparison

Price change

Madrigal Pharmaceuticals Inc Forecast

Price Target

By TipRanks

5.32% upside

12 Months Forecast

Average 584.09 USD 5.32%

High 670 USD

Low 523 USD

Based on 12 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Madrigal Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

263.2 / 277.1Support & Resistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

159 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.